Arabic Arabic English English French French German German
dark

FDA Approves Novel Treatment to Control Pain in Cats with Osteoarthritis, First Monoclonal Antibody Drug for Use in Any Animal Species

Today, the U.S. Food and Drug Administration approved Solensia (frunevetmab injection), the first treatment for the control of pain associated with osteoarthritis in cats and the first monoclonal antibody (mAb) new animal drug approved by the FDA for use in any animal species. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Anna Kotis Named President of imre Health

Next Post

Spago Nanomedicals Phase 1 Study with SpagoPix Shows Clear Contrast Enhancement and is Expanded into New Indications

Related Posts
Total
0
Share